TRIM5
is a host antiviral gene with an evolutionary history of genetic conflict with retroviruses. The
TRIMCyp
gene encodes a protein fusion of
TRIM5
effector domains with the capsid-binding ability of a retrotransposed
CyclophilinA
(
CypA
), resulting in novel antiviral specificity against lentiviruses. Previous studies have identified two independent primate
TRIMCyp
fusions that evolved within the past 6 My. Here, we describe an ancient primate
TRIMCyp
gene (that we call
TRIMCypA3
), which evolved in the common ancestor of simian primates 43 Mya. Gene reconstruction shows that
CypA3
encoded an intact, likely active,
TRIMCyp
antiviral gene, which was subject to selective constraints for at least 10 My, followed by pseudogenization or loss in all extant primates. Despite its decayed status, we found
TRIMCypA3
gene fusion transcripts in several primates. We found that the reconstructed “newly born”
TrimCypA3
encoded robust and broad retroviral restriction activity but that this broad activity was lost via eight amino acid changes over the course of the next 10 My. We propose that
TRIMCypA3
arose in response to a viral pathogen encountered by ancestral primates but was subsequently pseudogenized or lost due to a lack of selective pressure. Much like imprints of ancient viruses, fossils of decayed genes, such as
TRIMCypA3
, provide unique and specific insight into paleoviral infections that plagued primates deep in their evolutionary history.